Literature DB >> 2123231

Transport of lipid and apolipoproteins A-I and A-IV in intestinal lymph of the rat.

H Hayashi1, D F Nutting, K Fujimoto, J A Cardelli, D Black, P Tso.   

Abstract

Intestinal lipid absorption is associated with marked increases in the synthesis and secretion of apolipoprotein A-IV (apoA-IV) by the small intestine. Whether the increased intestinal apoA-IV synthesis and secretion results from increased fat uptake, increased cellular triglyceride (TG) content, or increased secretion of TG-rich lipoproteins by the enterocytes is unknown. Previous work from this laboratory has shown that a hydrophobic surfactant, Pluronic L-81 (L-81), is a potent inhibitor of intestinal formation of chylomicrons (CM), without reducing fat uptake or re-synthesis to TG. Furthermore, this inhibition can be reversed quickly by the cessation of L-81 infusion. Thus L-81 offers a unique opportunity to study the relationship between lymphatic TG, apoA-I and A-IV secretion. In this study, we studied the lymphatic transport of TG, apoA-I, and apoA-IV during both the inhibitory phase (L-81 infused together with lipid) and the subsequent unblocking phase (saline infusion). Two groups of lymph fistula rats were used, the control and the experimental rats. In the experimental rats, a phosphate-buffered taurocholate-stabilized emulsion containing 40 mumol [3H]triolein, 7.8 mumol of phosphatidylcholine, and 1 mg L-81 per 3 ml was infused at 3 ml/h for 8 h. This was then replaced by glucose-saline infusion for an additional 12 h. The control rats received the same lipid emulsion as the experimental rats, but without L-81 added, for 8 h. Lymph lipid was determined both by radioactivity and by glyceride-glycerol determination, and the apoA-I and apoA-IV concentrations were determined by rocket electroimmunophoresis assay. L-81 inhibited the rise in lymphatic lipid and apoA-IV output in the experimental rats after the beginning of lipid + L-81 infusion. Upon cessation of L-81 infusion, the mucosal lipid accumulated as a result of L-81 treatment was rapidly cleared into lymph as CM. This was associated with a marked increase in apoA-IV output; the maximal output was about 3 times that of the fasting level. There was a time lag of 4-5 h between the peak lymph lipid output and the peak lymph apoA-IV output during the unblocking phase in the experimental rats. There was also a comparable time lag between the maximal lipid and apoA-IV outputs in the control animals. Incorporation studies using [3H]leucine showed that apoA-IV synthesis was not stimulated during lipid + L-81 infusion, perhaps explaining the lack of increase in lymphatic A-IV secretion.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2123231

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  42 in total

Review 1.  Visceral perception: sensory transduction in visceral afferents and nutrients.

Authors:  H E Raybould
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

2.  Antibiotics Suppress Activation of Intestinal Mucosal Mast Cells and Reduce Dietary Lipid Absorption in Sprague-Dawley Rats.

Authors:  Hirokazu Sato; Linda S Zhang; Kristina Martinez; Eugene B Chang; Qing Yang; Fei Wang; Philip N Howles; Ryota Hokari; Soichiro Miura; Patrick Tso
Journal:  Gastroenterology       Date:  2016-07-18       Impact factor: 22.682

3.  Lipid transport in cholecystokinin knockout mice.

Authors:  Alexandra King; Qing Yang; Sarah Huesman; Therese Rider; Chunmin C Lo
Journal:  Physiol Behav       Date:  2015-07-11

4.  Intraperitoneal CCK and fourth-intraventricular Apo AIV require both peripheral and NTS CCK1R to reduce food intake in male rats.

Authors:  Chunmin C Lo; W Sean Davidson; Stephanie K Hibbard; Maria Georgievsky; Alexander Lee; Patrick Tso; Stephen C Woods
Journal:  Endocrinology       Date:  2014-02-24       Impact factor: 4.736

Review 5.  Using the cerebrospinal fluid to understand ingestive behavior.

Authors:  Stephen C Woods; Aaron A May; Min Liu; Patrick Tso; Denovan P Begg
Journal:  Physiol Behav       Date:  2016-12-05

6.  Identification of ApoA4 as a sphingosine 1-phosphate chaperone in ApoM- and albumin-deficient mice.

Authors:  Hideru Obinata; Andrew Kuo; Yukata Wada; Steven Swendeman; Catherine H Liu; Victoria A Blaho; Rieko Nagumo; Kenichi Satoh; Takashi Izumi; Timothy Hla
Journal:  J Lipid Res       Date:  2019-08-28       Impact factor: 5.922

7.  Apolipoprotein A-IV inhibits experimental colitis.

Authors:  Thorsten Vowinkel; Mikiji Mori; Christian F Krieglstein; Janice Russell; Fumito Saijo; Sulaiman Bharwani; Richard H Turnage; W Sean Davidson; Patrick Tso; D Neil Granger; Theodore J Kalogeris
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

Review 8.  Apolipoprotein A-IV: a protein intimately involved in metabolism.

Authors:  Fei Wang; Alison B Kohan; Chun-Min Lo; Min Liu; Philip Howles; Patrick Tso
Journal:  J Lipid Res       Date:  2015-02-01       Impact factor: 5.922

9.  Apolipoprotein A-IV enhances cholecystokinnin secretion.

Authors:  Jesse Zhan; Jonathan Weng; Brian G Hunt; W Sean Davidson; Min Liu; Chunmin C Lo
Journal:  Physiol Behav       Date:  2018-01-31

10.  Stimulation of Apolipoprotein A-IV expression in Caco-2/TC7 enterocytes and reduction of triglyceride formation in 3T3-L1 adipocytes by potential anti-obesity Chinese herbal medicines.

Authors:  Ava Jiangyang Guo; Roy Chi-yan Choi; Anna Wing-han Cheung; Jun Li; Ivy Xiaoying Chen; Tina Tingxia Dong; Karl Wah-keung Tsim; Brad Wing-chuen Lau
Journal:  Chin Med       Date:  2009-03-26       Impact factor: 5.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.